DMII (Drugs Made In America Acquisition II) Asset Impairment Charge: $0.00 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DMII Drugs Made In America Acquisition II Corp DMII
14 GF Score
Price $10.17
! 2 Warning Signs
View Full Analysis

What is Drugs Made In America Acquisition II Asset Impairment Charge?

Drugs Made In America Acquisition II DMII 14 Asset Impairment Charge is $0.00 Mil as of Jun. 2026. GuruFocus rates DMII with a GF Score™ of 14/100. The stock has 2 warning signs investors should review.

Drugs Made In America Acquisition II's Asset Impairment Charge for the three months ended in Jun. 2026 was $0.00 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Jun. 2026 was $0.00 Mil.

Drugs Made In America Acquisition II Asset Impairment Charge Related Terms

Drugs Made In America Acquisition II Asset Impairment Charge Historical Data

* Premium members only.

The historical data trend for Drugs Made In America Acquisition II's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Drugs Made In America Acquisition II Asset Impairment Charge Chart

Drugs Made In America Acquisition II Annual Data
Trend Dec24 Dec25
Asset Impairment Charge
0.00 0.00

Drugs Made In America Acquisition II Quarterly Data
Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Asset Impairment Charge Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00
DMII
14GF Score
Drugs Made In America Acquisition II Corp DMII
Asset Impairment Charge is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Drugs Made In America Acquisition II Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

What does a Asset Impairment Charge of $0.00 Mil mean?
Drugs Made In America Acquisition II (DMII) has a Asset Impairment Charge of $0.00 Mil as of Jun. 2026.
Is Drugs Made In America Acquisition II's Asset Impairment Charge too high?
Drugs Made In America Acquisition II's current Asset Impairment Charge is $0.00 Mil. Overall, Drugs Made In America Acquisition II has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Drugs Made In America Acquisition II's Asset Impairment Charge compare to EVAC and CXII?
Drugs Made In America Acquisition II's Asset Impairment Charge of $0.00 Mil can be compared against companies in the Diversified Financial Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Asset Impairment Charge for a Diversified Financial Services company?
A good Asset Impairment Charge depends on the Diversified Financial Services industry context. However, Asset Impairment Charge should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Asset Impairment Charge mean?
A high Asset Impairment Charge can signal that a stock is expensive relative to its fundamentals. Drugs Made In America Acquisition II's current Asset Impairment Charge is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Drugs Made In America Acquisition II stock overvalued right now?
Drugs Made In America Acquisition II (DMII) has a current Asset Impairment Charge of $0.00 Mil. The current Asset Impairment Charge is $0.00 Mil. Drugs Made In America Acquisition II's overall GF Score™ is 14/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Asset Impairment Charge calculated?
Asset Impairment Charge is calculated from a company's financial statements. For Drugs Made In America Acquisition II (DMII), the current Asset Impairment Charge is $0.00 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Drugs Made In America Acquisition II Business Description

Address 420 Lexington Avenue, Suite 1402, New York, NY, USA, 10170
Drugs Made In America Acquisition II Corp is a blank check Company.
14GF Score

Get the complete analysis for DMII

Asset Impairment Charge is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$10.17
Price